Handa Pharmaceuticals (Rights to Generic Dexilant) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Handa Pharmaceuticals (Rights to Generic Dexilant) General Information

Description

Distribution and marketing rights of generic dexlansoprazole capsules.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 39465 Paseo Padre Parkway
  • Fremont, CA 94538
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Delivery
Other Commercial Services
Acquirer
Par Pharmaceutical Companies
Corporate Office
  • 39465 Paseo Padre Parkway
  • Fremont, CA 94538
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Handa Pharmaceuticals (Rights to Generic Dexilant) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Handa Pharmaceuticals (Rights to Generic Dexilant)‘s full profile, request access.

Request a free trial

Handa Pharmaceuticals (Rights to Generic Dexilant) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Handa Pharmaceuticals (Rights to Generic Dexilant)‘s full profile, request access.

Request a free trial

Handa Pharmaceuticals (Rights to Generic Dexilant) FAQs

  • Where is Handa Pharmaceuticals (Rights to Generic Dexilant) headquartered?

    Handa Pharmaceuticals (Rights to Generic Dexilant) is headquartered in Fremont, CA.

  • What industry is Handa Pharmaceuticals (Rights to Generic Dexilant) in?

    Handa Pharmaceuticals (Rights to Generic Dexilant)’s primary industry is Buildings and Property.

  • Is Handa Pharmaceuticals (Rights to Generic Dexilant) a private or public company?

    Handa Pharmaceuticals (Rights to Generic Dexilant) is a Private company.

  • What is Handa Pharmaceuticals (Rights to Generic Dexilant)’s current revenue?

    The current revenue for Handa Pharmaceuticals (Rights to Generic Dexilant) is 000000.

  • Who are Handa Pharmaceuticals (Rights to Generic Dexilant)’s investors?

    Handa Pharma has invested in Handa Pharmaceuticals (Rights to Generic Dexilant).

  • When was Handa Pharmaceuticals (Rights to Generic Dexilant) acquired?

    Handa Pharmaceuticals (Rights to Generic Dexilant) was acquired on 19-Apr-2012.

  • Who acquired Handa Pharmaceuticals (Rights to Generic Dexilant)?

    Handa Pharmaceuticals (Rights to Generic Dexilant) was acquired by Par Pharmaceutical Companies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »